Healthcare
F.D.A. Approves Moderna's mRNA Flu Vaccine
The agency had initially refused to even review the application but reversed course after a public outcry.


Glideslope AI-powered market news
No market stories in the last 7 days. The latest coverage is below.

No scored stories in the last 7 days.
| Day | Mood | Stories |
|---|---|---|
| Sat, Oct 10 | — | 0 |
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | — | 0 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 0 |
The agency had initially refused to even review the application but reversed course after a public outcry.

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE